Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
|
Pain
|
2009
|
2.69
|
2
|
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.
|
Pain
|
2012
|
1.88
|
3
|
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
|
Pain
|
2013
|
1.64
|
4
|
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.
|
Pain Pract
|
2011
|
1.50
|
5
|
Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
|
Diabetes Care
|
2007
|
1.03
|
6
|
Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes.
|
Muscle Nerve
|
2007
|
0.94
|
7
|
Predictors of premature discontinuation of treatment in multiple disease states.
|
Patient Prefer Adherence
|
2009
|
0.90
|
8
|
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
|
Mayo Clin Proc
|
2011
|
0.89
|
9
|
A closer look at the baseline-observation-carried-forward (BOCF).
|
Patient Prefer Adherence
|
2010
|
0.88
|
10
|
Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
|
Chin Med J (Engl)
|
2010
|
0.84
|
11
|
Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain.
|
Eur Spine J
|
2013
|
0.79
|
12
|
A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative.
|
Pain
|
2012
|
0.78
|
13
|
A stroke-like presentation of glioblastoma multiforme.
|
J Stroke Cerebrovasc Dis
|
2003
|
0.78
|